Addex Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$115
$234
$153
$153
Gross Profit
115
235
-1,392
EBITDA
-1,316
-785
-2,589
EBIT
-1,428
-788
-2,669
Net Income
12,878
-3,087
-2,856
-2,856
Net Change In Cash
115
234
153
153
Free Cash Flow
-2,757
-2,193
-624
-624
Cash
3,787
1,627
3,865
3,865
Basic Shares
97,534
97,534
125,195
95,236

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$1,612
$1,422
$2,916
$3,612
Gross Profit
-5,322
-13,201
-9,902
-6,760
EBITDA
-9,911
-20,167
-15,152
-11,829
EBIT
-10,217
-20,490
-15,500
-12,207
Net Income
-10,556
-20,804
-15,351
-12,858
Net Change In Cash
1,612
1,422
2,916
3,612
Free Cash Flow
-7,999
-16,437
-14,736
-12,239
Cash
3,865
6,957
20,484
18,695
Basic Shares
74,307
45,184
34,119
26,681

Earnings Calls

Quarter EPS
2024-09-30
$10.17
2024-03-31
-$4.05
2023-09-30
-$4.59
2023-06-30
-$0.04